NCT05851196

Brief Summary

Patients with non-specific low back pain will be compared to healthy, age- and sex-matched controls to determine the most discriminating back muscle characteristics and to delineate possible phenotypes of patients with non-specific low back pain showing impaired proprioceptive postural control. Additionally, the group of patients with non-specific low back pain will receive a 16-week, high-load proprioceptive training program. The effects of this training program on the different back muscle characteristics and proprioceptive postural control will be evaluated.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
20mo left

Started Jan 2024

Longer than P75 for all trials

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
Jan 2024Dec 2027

First Submitted

Initial submission to the registry

April 7, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 9, 2023

Completed
8 months until next milestone

Study Start

First participant enrolled

January 15, 2024

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2027

Last Updated

February 28, 2024

Status Verified

February 1, 2024

Enrollment Period

3 years

First QC Date

April 7, 2023

Last Update Submit

February 26, 2024

Conditions

Keywords

Proprioceptive postural controlMuscle volumeMuscle activationMuscle oxygenationMuscle fiber type compositionProprioceptive training

Outcome Measures

Primary Outcomes (23)

  • Proprioceptive postural control at baseline 1 (t= 0 weeks)

    Center-of-pressure displacement in response to ankle and/or back muscle vibration and the Relative Proprioceptive Weighting ratio will be calculated.

    At baseline 1 (t= 0 weeks)

  • Proprioceptive postural control at baseline 2 (t= 8 weeks) (only for patients)

    Center-of-pressure displacement in response to ankle and/or back muscle vibration and the Relative Proprioceptive Weighting ratio will be calculated.

    At baseline 2 (t= 8 weeks)

  • Proprioceptive postural control after 8 weeks of training (t= 16 weeks) (only for patients)

    Center-of-pressure displacement in response to ankle and/or back muscle vibration and the Relative Proprioceptive Weighting ratio will be calculated.

    After 8 weeks of training (t= 16 weeks)

  • Proprioceptive postural control after 16 weeks of training (t= 24 weeks) (only for patients)

    Center-of-pressure displacement in response to ankle and/or back muscle vibration and the Relative Proprioceptive Weighting ratio will be calculated.

    After 16 weeks of training (t= 24 weeks)

  • Proprioceptive postural control 16 weeks after the end of training (t= 40 weeks) (only for patients)

    Center-of-pressure displacement in response to ankle and/or back muscle vibration and the Relative Proprioceptive Weighting ratio will be calculated.

    16 weeks after the end of training (t= 40 weeks)

  • Macroscopic characteristiscs of the lumbar multifidus and erector spinae muscles at t= 0 weeks (only for healthy controls)

    Muscle volume and quality will be measured with 3D freehand ultrasound, muscle cross-sectional area and thickness will be evaluated with 2D ultrasound.

    At t= 0 weeks

  • Macroscopic characteristiscs of the lumbar multifidus and erector spinae muscles at baseline 2 (t= 8 weeks) (only for patients)

    Muscle volume and quality will be measured with 3D freehand ultrasound, muscle cross-sectional area and thickness will be evaluated with 2D ultrasound.

    At baseline 2 (t= 8w, 2nd baseline)

  • Macroscopic characteristics of the lumbar multifidus and erector spinae muscles after 16 weeks of training (t= 24 weeks) (only for patients)

    Muscle volume and quality will be measured with 3D freehand ultrasound, muscle cross-sectional area and thickness will be evaluated with 2D ultrasound.

    After 16 weeks of training (t= 24 weeks)

  • Macroscopic characteristisc of the lumbar multifidus and erector spinae muscles 16 weeks after the end of training (t= 40 weeks) (only for patients)

    Muscle volume and quality will be measured with 3D freehand ultrasound, muscle cross-sectional area and thickness will be evaluated with 2D ultrasound.

    16 weeks after the end of training (t= 40 weeks)

  • Microscopic muscle characteristics of the lumbar multifidus and erector spinae muscles at t= 0 weeks (only for healthy controls)

    Fine-needle biopsies of the lumbar multifidus and erector spinae muscles will be acquired.

    At t= 0 weeks

  • Microscopic muscle characteristics of the lumbar multifidus and erector spinae muscles at baseline 2 (t= 8 weeks) (only for patients)

    Fine-needle biopsies of the lumbar multifidus and erector spinae muscles will be acquired.

    At baseline 2 (t= 8 weeks)

  • Microscopic muscle characteristics of the lumbar multifidus and erector spinae muscles after 16 weeks of training (t= 24 weeks) (only for patients)

    Fine-needle biopsies of the lumbar multifidus and erector spinae muscles will be acquired.

    After 16 weeks of training (t= 24 weeks)

  • Microscopic muscle characteristics of the lumbar multifidus and erector spinae muscles 16 weeks after the end of training (t= 40 weeks) (only for patients)

    Fine-needle biopsies of the lumbar multifidus and erector spinae muscles will be acquired.

    16 weeks after the end of training (t= 40 weeks)

  • Hemodynamic muscle characteristics of the lumbar multifidus and erector spinae muscles at baseline 1 (t= 0 weeks)

    The Tissue Oxygenation Index will be recorded continuously with near-infrared spectroscopy during different functional postures (prone lying, usual sitting, usual standing, standing with the trunk bent 25° forward).

    At baseline 1 (t= 0 weeks)

  • Hemodynamic muscle characteristics of the lumbar multifidus and erector spinae muscles at baseline 2 (t= 8 weeks) (only for patients)

    The Tissue Oxygenation Index will be recorded continuously with near-infrared spectroscopy during different functional postures (prone lying, usual sitting, usual standing, standing with the trunk bent 25° forward).

    At baseline 2 (t= 8 weeks)

  • Hemodynamic muscle characteristics of the lumbar multifidus and erector spinae muscles after 8 weeks of training (t= 16 weeks) (only for patients)

    The Tissue Oxygenation Index will be recorded continuously with near-infrared spectroscopy during different functional postures (prone lying, usual sitting, usual standing, standing with the trunk bent 25° forward).

    After 8 weeks of training (t= 16 weeks)

  • Hemodynamic muscle characteristics of the lumbar multifidus and erector spinae muscles after 16 weeks of training (t= 24 weeks) (only for patients)

    The Tissue Oxygenation Index will be recorded continuously with near-infrared spectroscopy during different functional postures (prone lying, usual sitting, usual standing, standing with the trunk bent 25° forward).

    After 16 weeks of training (t= 24 weeks)

  • Hemodynamic muscle characteristics of the lumbar multifidus and erector spinae muscles 16 weeks after the end of training (t= 40 weeks) (only for patients)

    The Tissue Oxygenation Index will be recorded continuously with near-infrared spectroscopy during different functional postures (prone lying, usual sitting, usual standing, standing with the trunk bent 25° forward).

    16 weeks after the end of training (t= 40 weeks)

  • Electrophysiological muscle characteristics of the lumbar multifidus and erector spinae at baseline 1 (t= 0 weeks)

    Muscle activitation levels and patterns will be measured with surface electromyography during different functional postures (prone lying, usual sitting, usual standing, standing with the trunk bent 25° forward).

    At baseline 1 (t= 0 weeks)

  • Electrophysiological muscle characteristics of the lumbar multifidus and erector spinae at baseline 2 (t= 8 weeks) (only for patients)

    Muscle activitation levels and patterns will be measured with surface electromyography during different functional postures (prone lying, usual sitting, usual standing, standing with the trunk bent 25° forward).

    At baseline 2 (t= 8 weeks)

  • Electrophysiological muscle characteristics of the lumbar multifidus and erector spinae after 8 weeks of training (t= 16 weeks) (only for patients)

    Muscle activitation levels and patterns will be measured with surface electromyography during different functional postures (prone lying, usual sitting, usual standing, standing with the trunk bent 25° forward).

    After 8 weeks of training (t= 16 weeks)

  • Electrophysiological muscle characteristics of the lumbar multifidus and erector spinae after 16 weeks of training (t= 24 weeks) (only for patients)

    Muscle activitation levels and patterns will be measured with surface electromyography during different functional postures (prone lying, usual sitting, usual standing, standing with the trunk bent 25° forward).

    After 16 weeks of training (t= 24 weeks)

  • Electrophysiological muscle characteristics of the lumbar multifidus and erector spinae 16 weeks after the end of training (t= 40 weeks) (only for patients)

    Muscle activitation levels and patterns will be measured with surface electromyography during different functional postures (prone lying, usual sitting, usual standing, standing with the trunk bent 25° forward).

    16 weeks after the end of training (t= 40 weeks)

Secondary Outcomes (7)

  • Disability due to low back pain

    Controls: once, immediately after inclusion, Patients: 5 times, immediately after inclusion (t= 0w), after 8 weeks (t= 8w, 2nd baseline), after 8 weeks of training (t= 16w), after 16 weeks of training (t= 24w), 16 weeks after the end of training (t= 40w)

  • Risk for future work disability due to low back pain

    Controls: once, immediately after inclusion, Patients: 5 times, immediately after inclusion (t= 0w), after 8 weeks (t= 8w, 2nd baseline), after 8 weeks of training (t= 16w), after 16 weeks of training (t= 24w), 16 weeks after the end of training (t= 40w)

  • Pain-related fear of movement

    Controls: once, immediately after inclusion, Patients: 5 times, immediately after inclusion (t= 0w), after 8 weeks (t= 8w, 2nd baseline), after 8 weeks of training (t= 16w), after 16 weeks of training (t= 24w), 16 weeks after the end of training (t= 40w)

  • Fear-avoidance beliefs about physical activity and work

    Controls: once, immediately after inclusion, Patients: 5 times, immediately after inclusion (t= 0w), after 8 weeks (t= 8w, 2nd baseline), after 8 weeks of training (t= 16w), after 16 weeks of training (t= 24w), 16 weeks after the end of training (t= 40w)

  • Pain catastrophizing

    Controls: once, immediately after inclusion, Patients: 5 times, immediately after inclusion (t= 0w), after 8 weeks (t= 8w, 2nd baseline), after 8 weeks of training (t= 16w), after 16 weeks of training (t= 24w), 16 weeks after the end of training (t= 40w)

  • +2 more secondary outcomes

Other Outcomes (10)

  • Age

    Immediately after inclusion

  • Sex (male/female)

    Immediately after inclusion

  • Highest level of education

    Immediately after inclusion

  • +7 more other outcomes

Study Arms (2)

Patients with non-specific low back pain

Individuals with chronic non-specific ow back pain

Other: Proprioceptive training

Healthy controls

Healthy, age- and sex-matched individuals without low back pain

Interventions

A physiotherapist tailors the exercises to the patient's functional demands and pain- or fear-inducing activities. Guided by the therapist, patients look for ways to integrate the exercises into their daily life activities. Each week, patients receive feedback from the physiotherapist, and the training program is gradually progressed. The patients are instructed to perform the exercises daily, integrated into their daily activities, hobbies, and work. The program contains: (1) exercises to improve the sense of posture and movement, (2) exercises to correct the reference frame from which patients control posture and movement, (3) muscle control exercises, (4) exercises to increase variability in postures and movement patterns, (5) functionality: patients search for ways to correct and integrate alternative postures and movement patterns into their daily life, (6) high training frequency and high load, (7) focus on sensing, localizing and differentiating, rather than movement control.

Patients with non-specific low back pain

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Flemish Brabant

You may qualify if:

  • Patients with non-specific low back pain:
  • Aged 18-60 years
  • Non-specific low back pain without radicular leg pain
  • Mechanical low back pain with episodes of \<4 on the numerical pain rating scale and episodes of \>6 on the numerical pain rating scale
  • Non-specific low back pain for three months or more
  • Score of 20% or more on the Modified Low Back Pain Disability Questionnaire
  • Informed consent to participate
  • Healthy controls:
  • Aged 18-60 years
  • No history of low back pain needing medical treatment or resulting in a limited activity level
  • No low back pain in the previous six months
  • Informed consent to participate

You may not qualify if:

  • Pregnancy
  • Previous trauma or surgery to the spine, pelvis or lower limbs
  • Structural spinal deformity (e.g., scoliosis)
  • Neurological, neuromuscular, respiratory or systemic disease
  • Central sensitization: score of 50/100 or more on the Central Sensitization Inventory
  • Specific vestibular or balance problems
  • Acute lower limb or neck problems
  • Body mass index of 30 kg/m² or more

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

REVAL Rehabilitation Research Center, Hasselt University

Diepenbeek, 3500, Belgium

RECRUITING

Department of Rehabilitation Sciences, KU Leuven

Leuven, 3001, Belgium

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Muscle biopsies of the lumbar multifidus and erector spinae

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Lotte Janssens, PhD

    Hasselt University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Lotte Janssens, PhD

CONTACT

Simon Brumagne, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

April 7, 2023

First Posted

May 9, 2023

Study Start

January 15, 2024

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Last Updated

February 28, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will not share

Locations